Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

USask researchers receive almost $1 million to fight new coronavirus

A University of Saskatchewan research team and collaborating scientists from across the country have been awarded almost $1 million over two years to develop animal models and test vaccine candidates for effectiveness and safety against the new coronavirus (SARS-CoV-2).

7 Mar 2020

Researchers map key atomic structures in measles, mumps, flu and RSV

Northwestern University researchers have, for the first time, determined the 3D atomic structure of a key complex in paramyxoviruses, a family of viruses that includes measles, mumps, human parainfluenza and respiratory syncytial virus.

17 Feb 2020

Airway Therapeutics receives funding to advance BPD treatment

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the injury cycle of inflammation for patients with respiratory and inflammatory diseases, announced today the closing of a $15.5 million oversubscribed Series C financing round.

8 Jan 2020

Higher temperatures and increased rainfall could make RSV epidemics less severe, more common

One of the first studies to examine the effect of climate change on diseases such as influenza that are transmitted directly from person to person has found that higher temperatures and increased rainfall could make outbreaks less severe but more common, particularly in North America.

16 Dec 2019

Vanderbilt doctors offer tips on when to seek ED treatment for flu-like symptoms

'Tis the season for colds, flu and upper respiratory illnesses say health care providers at Monroe Carell Jr. Children's Hospital at Vanderbilt.

11 Dec 2019

NTU scientists find potential route to disabling viruses causing severe respiratory diseases

A team of molecular and structural biologists from Nanyang Technological University, Singapore have found a potential new route to disabling respiratory syncytial virus and human metapneumovirus after elucidating the structure of one of its key components.

9 Dec 2019

Common cold virus could infect fetus via placenta

According to researchers, the common cold viruses are capable of infecting human placental cells and may thus transmit the infection to the fetus in the womb during pregnancy. The new study was published in the journal PLOS ONE, and provides the first concrete proof that this type of carriage is possible.

3 Dec 2019

New discovery brings scientists closer to developing an RSV vaccine

Scientists have made an important discovery that could lead to a vaccine that will protect against respiratory syncytial virus (RSV).

9 Oct 2019

Scientists discover lung cell that can hustle to repair its damaged DNA and survive influenza

Scientists at Duke University have identified one kind of lung cell that can hustle to repair its damaged DNA and survive an attack of the influenza A virus while other kinds of cells around it die in droves.

30 Jul 2019

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019

Global study reveals viruses as important cause of childhood pneumonia

Respiratory syncytial virus and other viruses now appear to be the main causes of severe childhood pneumonia in low- and middle-income countries, highlighting the need for vaccines against these pathogens, according to a study from a consortium of scientists from around the world, led by a team at the Johns Hopkins Bloomberg School of Public Health.

28 Jun 2019

Coat of proteins makes viruses more infectious and facilitates plaque formation in Alzheimer's

New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface.

27 May 2019

Infants with bronchiolitis are at increased risk of hospitalization for asthma in preschool years

Infants who are admitted to hospital with the common infection bronchiolitis are at increased risk of further emergency hospital admissions for asthma, wheezing and respiratory illness in the first five years of their life.

6 Mar 2019

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

A promising, effective vaccine for common respiratory disease

Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance protection against this serious disease and reduce inflammation in the body after exposure to the virus, according to a study led by Georgia State University.

18 Dec 2018

Houston Methodist launches real-time website to track flu cases

Pathologists at Houston Methodist developed a real-time website to track flu cases, just in time to assist physicians, the CDC and patients for the fall 2018 flu season.

7 Dec 2018

Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance

As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such threats calls for the rapid identification of the causative agent.

6 Dec 2018

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can "neutralize" the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.

21 Nov 2018

NIAID launches clinical trial of investigational RSV vaccine

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus.

14 Jun 2018

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.

22 May 2018

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

USask researchers receive almost $1 million to fight new coronavirus

Researchers map key atomic structures in measles, mumps, flu and RSV

Airway Therapeutics receives funding to advance BPD treatment

Higher temperatures and increased rainfall could make RSV epidemics less severe, more common

Vanderbilt doctors offer tips on when to seek ED treatment for flu-like symptoms

NTU scientists find potential route to disabling viruses causing severe respiratory diseases

Common cold virus could infect fetus via placenta

New discovery brings scientists closer to developing an RSV vaccine

Scientists discover lung cell that can hustle to repair its damaged DNA and survive influenza

Comprehensive gene activity database could significantly reduce animal use

Global study reveals viruses as important cause of childhood pneumonia

Coat of proteins makes viruses more infectious and facilitates plaque formation in Alzheimer's

Infants with bronchiolitis are at increased risk of hospitalization for asthma in preschool years

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

A promising, effective vaccine for common respiratory disease

Houston Methodist launches real-time website to track flu cases

Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

NIAID launches clinical trial of investigational RSV vaccine

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in